angiotensin ii has been researched along with Oral Submucous Fibrosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gadbail, A; Gondivkar, S; Gopalakrishnan, D; Patil, S; Sarode, GS; Sarode, SC | 1 |
1 other study(ies) available for angiotensin ii and Oral Submucous Fibrosis
| Article | Year |
|---|---|
Oral submucous fibrosis and COVID-19: Perspective on comorbidity.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Betacoronavirus; Comorbidity; Coronavirus Infections; COVID-19; Down-Regulation; Humans; Mouth; Oral Submucous Fibrosis; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Prevalence; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2020 |